Skip to content

Reinfection after hepatitis C cure: prevention may require long-term support for people who have injected drugs

Harm reduction for people who inject drugs in New York has worked, but hasn’t reduced racial inequality

Opioid substitution treatment increases chances that people who inject drugs will have good adherence to HIV therapy

HCV sexual transmission linked to anal sex, drug use, lower CD4 count

HCV prevention campaigns need to focus on reducing frequency of injecting drug use involving sharing of equipment

Reduced physical function significantly increases mortality risk of middle-aged people living with HIV

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

Young drug injectors on opioid maintenance therapy have lower risk of hepatitis C infection

People living with HIV in the US are infrequently screened for HCV